WHO IRISopen access
Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs
who guideline, tuberculosis, multidrug-resistant, antitubercular agents, guideline, communicable diseases and their control, drug therapy, administration and dosage
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 660643
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.